1. A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD‐ON). Issue 7 (11th February 2014) Authors: Mathieu, C.; Rodbard, H. W.; Cariou, B.; Handelsman, Y.; Philis‐Tsimikas, A.; Ocampo Francisco, A. M.; Rana, A.; Zinman, B.; on behalf of the BEGIN: VICTOZA ADD‐ON (NN1250‐3948) study group Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 7(2014:Jul.) Page Start: 636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial. Issue 11 (30th September 2013) Authors: Rodbard, H. W.; Cariou, B.; Zinman, B.; Handelsman, Y.; Philis‐Tsimikas, A.; Skjøth, T. V.; Rana, A.; Mathieu, C. Journal: Diabetic medicine Issue: Volume 30:Issue 11(2013:Nov.) Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2‐year trial in insulin‐naïve patients with type 2 diabetes. Issue 9 (27th February 2014) Authors: Rodbard, H. W.; Cariou, B.; Zinman, B.; Handelsman, Y.; Wolden, M. L.; Rana, A.; Mathieu, C. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 9(2014:Sep.) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗